China National Medicines Corp Ltd (600511) — Financial Flexibility Index
China National Medicines Corp Ltd (600511) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of CN¥-520.16 Million (operating CF CN¥-540.00 Million minus capex CN¥19.84 Million) represents 0% of total liabilities (CN¥15.19 Billion). Check 600511 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China National Medicines Corp Ltd Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for China National Medicines Corp Ltd across 24 annual periods. For the full cash flow conversion analysis, see cash flow conversion of China National Medicines Corp Ltd.
Annual Financial Flexibility Index for China National Medicines Corp Ltd (2001–2024)
Year-by-year free cash flow to debt coverage for China National Medicines Corp Ltd. Explore China National Medicines Corp Ltd (600511) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | CN¥1.79 Billion | CN¥1.66 Billion | CN¥15.95 Billion | ▼ -41.7% |
| 2023 | 0.19x | CN¥2.87 Billion | CN¥2.73 Billion | CN¥14.92 Billion | ▲ +4.8% |
| 2022 | 0.18x | CN¥2.52 Billion | CN¥2.40 Billion | CN¥13.75 Billion | ▲ +17.4% |
| 2021 | 0.16x | CN¥2.05 Billion | CN¥1.96 Billion | CN¥13.12 Billion | ▲ +34.8% |
| 2020 | 0.12x | CN¥1.37 Billion | CN¥1.30 Billion | CN¥11.81 Billion | ▼ -25.0% |
| 2019 | 0.15x | CN¥1.86 Billion | CN¥1.78 Billion | CN¥12.03 Billion | ▲ +51.4% |
| 2018 | 0.10x | CN¥1.11 Billion | CN¥981.65 Million | CN¥10.90 Billion | ▼ -4.6% |
| 2017 | 0.11x | CN¥1.15 Billion | CN¥1.07 Billion | CN¥10.71 Billion | ▼ -42.5% |
| 2016 | 0.19x | CN¥631.13 Million | CN¥591.25 Million | CN¥3.38 Billion | ▲ +11.5% |
| 2015 | 0.17x | CN¥508.75 Million | CN¥440.29 Million | CN¥3.04 Billion | ▲ +34.7% |
| 2014 | 0.12x | CN¥367.17 Million | CN¥218.94 Million | CN¥2.96 Billion | ▲ +16.5% |
| 2013 | 0.11x | CN¥307.22 Million | CN¥185.56 Million | CN¥2.88 Billion | ▼ -19.4% |
| 2012 | 0.13x | CN¥355.52 Million | CN¥185.87 Million | CN¥2.69 Billion | ▲ +185.6% |
| 2011 | -0.15x | CN¥-311.60 Million | CN¥-370.56 Million | CN¥2.02 Billion | ▼ -192.4% |
| 2010 | 0.17x | CN¥342.30 Million | CN¥318.21 Million | CN¥2.05 Billion | ▲ +1.9% |
| 2009 | 0.16x | CN¥277.51 Million | CN¥255.18 Million | CN¥1.69 Billion | ▼ -20.7% |
| 2008 | 0.21x | CN¥233.30 Million | CN¥217.10 Million | CN¥1.13 Billion | ▲ +188.6% |
| 2007 | 0.07x | CN¥88.09 Million | CN¥79.48 Million | CN¥1.23 Billion | ▼ -62.0% |
| 2006 | 0.19x | CN¥145.31 Million | CN¥121.50 Million | CN¥771.05 Million | ▲ +7.2% |
| 2005 | 0.18x | CN¥133.44 Million | CN¥92.20 Million | CN¥759.27 Million | ▼ -9.1% |
| 2004 | 0.19x | CN¥136.26 Million | CN¥49.18 Million | CN¥704.48 Million | ▲ +31.1% |
| 2003 | 0.15x | CN¥91.44 Million | CN¥526.15K | CN¥619.80 Million | ▲ +105.2% |
| 2002 | 0.07x | CN¥29.38 Million | CN¥15.19 Million | CN¥408.75 Million | ▲ +381.7% |
| 2001 | -0.03x | CN¥-7.68 Million | CN¥-11.80 Million | CN¥300.99 Million | — |